Oncocyte Corporation (OCX) Fundamentals

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States, and it earns revenue from the sale of diagnostic tests.
SHARE INFORMATION
Market Cap$ 107,817,407
Shares Outstanding125,369,078
Float85,420,617
Percent Float68.14%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 7,727,000
Latest Fiscal EPS$ -0.72
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions194
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months1,008,504
Institutional Holdings Percent53.2%
Institutional Sold Previous 3 Months4,120,609
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months335,000
Insider Holdings Percent4.3
Insider Sold Previous 3 Months192,514
Insider Shares Owned5,152,231
TRADING INFO
52 Week High$ 5.48
52 Week Low$ 0.81
52 Week High Change$ -83.14
21 Day Moving Average$ 0.8824
21 Day Extended Moving Average$ 0.896641
50 Day Moving Average$ 0.955
50 Day Extended Moving Average$ 0.959924
200 Day Moving Average$ 1.6332
200 Day Extended Moving Average$ 1.6858
10 Day Average Volume212,179
20 Day Average Volume222,475
30 Day Average Volume277,064
50 Day Average Volume494,840
Alpha0.003453
Beta1.7635
Standard Deviation0.400368
R20.048532
7 Day Price Change$ 0.01
7 Day Percent Change1.18%
21 Day Price Change$ -0.0366
21 Day Percent Change-4.08%
30 Day Price Change$ -0.0411
30 Day Percent Change-4.56%
Month to Date Price Change$ 0.0234
Month to Date Percent Change2.8%
Quarter to Date Price Change$ -0.0397
Quarter to Date Percent Change-4.41%
180 Day Price Change$ -0.84
180 Day Percent Change-49.41%
200 Day Price Change$ -0.825
200 Day Percent Change-48.96%
Year to Date Price Change$ -1.31
Year to Date Percent Change-60.37%

Oncocyte Corporation (OCX) Key Ratios

PROFITABILITY
EBIT Margin-896.9%
EBITDA Margin-834.7%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin-5.3%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 5,997,000
Revenue Per Share$ 0.0478
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-2.30
Total Debt To Equity0.10
Int Coverage-421.00
Current Ratio1.80
Leverage Ratio2.50
Quick Ratio1.70
Long Term Debt To Capital0.06
VALUATION MEASURES
PE Ratio-1.20
Enterprise Value$ 103,198,013
Price to Sales17.9786
Price to Free Cash-3.50
PE High Last 5 Years-7.60
Price To Book2.10
Price To Cash Flow0.00
PE Low Last 5 Years-8.40
Price to Tangible Book-2.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover5.20
Invoice Turnover49.60
Assets Turnover0.10
Return Assets-52.52
Return on Equity-89.40
Return on Capital-79.50

Oncocyte Corporation (OCX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorWithumSmith+Brown, PC
CEORonald A. Andrews
Emplyoees115
Last AuditUQ
CIK0001642380
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address15 Cushing
Irvine, CA 92618
Websitehttps://www.oncocyte.com
Facsimile-
Telephone+1 949 409-7600
EmailAPrior@evcgroup.com


Your Recent History
NASDAQ
OCX
Oncocyte
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.